Female sexual disorder (FSD) is characterized by the inability to achieve or maintain sexual arousal necessary for satisfactory sexual intercourse. The quality of life diminishes when a woman suffers from FSD. It causes stress and depression. Sexual problems can occur at any age. Factors such as stages in life, cultural, medical and psychiatric influences play a major role in causing sexual dysfunction. There are various FSD treatments available on the market that help women recover from sexual dysfunction and resume their sex life.
A recent study on 4037 women from the UK and 3080 from Australia revealed that there is a significant impact of genetics on the orgasmic capacity of a woman. About one-third of the women said that they did not achieve an orgasm during sexual intercourse and about 21% said that they only achieved an orgasm during masturbation. Around 34% of the women in the UK and 32% in Australia were affected by genetics. This shows that there are wide variations in orgasmic functions of women and they have a strong genetic base.
Clitoral length is inconsistent while vaginal length is not. Given the connection between the range of clitoral structures and capacity to get an orgasm, the marked inconsistency in clitoral size is not indicative of evolutionary variety bias for clitoral formation and on female orgasm.
Genetics also influence vulnerability to sexual dysfunction. Women with type II genotype were 8 times more likely to have a sexual dysfunction if they consumed oral medication and contraceptives.
A study conducted in various colleges revealed that only 14% to 17% of the women spoke with their doctors about FSD. Most women never spoke with their doctors about sex or any other topic related to sex. In most cases, the doctor initiated the discussion and most women believed that their doctors would not be approachable to discuss their sexual problems. They also felt that the doctor lacked interest in many cases and this may leave them embarrassed. Here are the findings of the study:
The prevalence and likelihood of FSD is more amongst women who are stressed by work and relationships.
It could not be established whether menopausal status was associated with changes in sexual functions.
A meta-analysis of the prevalence and incidence of FSD showed that FSD are highly common across cultures.
There is a direct correlation between the age and incidence of FSD. The frequency of symptoms of FSD increases with age but distress and trauma because of those symptoms decrease with age.
The role of culture was not as imperative as troublesome medical history.
If you are a woman, who suffers from FSD, then treating yourself with Intrinsa patches is one of the best alternatives for you. These patches can be bought online and a lot of money and time can be saved. Intrinsa is a testosterone patch designed to treat FSD. It works by releasing testosterone through the skin in the bloodstream so that testosterone levels come back to normal. These patches are a form of FSD treatment.